In Focus

Patients fighting life-threatening illnesses who have run out of conventional options will get a chance to try some of the most cutting-edge treatments available, through a national effort that just received nearly $4.8 million in funding from the federal government.

Based at the University of Michigan, in partnership with Duke University, the University of Texas Southwestern Medical Center and the University of Rochester, the effort will build a national framework to help more patients gain access to experimental drugs, devices and biologics. It is funded by the National Center for Advancing Translational Sciences, part of the National Institutes of Health.

CBSSM News & Events

Reshma Jagsi & Andrew Barnosky are 2018 Dean's Award Recipients
CBSSM's Director, Reshma Jagsi, M.D., D.Phil., was selected to receive the 2017 Clinical and Health Services Research Award from the Dean's Awards program. Andrew R. Barnosky, D.O., MPH was awarded the Lifetime Achievement Award in Medical Education.
Read more.
Newly published study on public attitudes toward selling access to human specimens 09/07/2018
A new University of Michigan survey documents public attitudes toward potential commercial use of these samples.
Read more.
CBSSM Working Group Meeting-Sameer Saini/Elissa Ozanne 09/25/2018
Sameer Saini, MD, MS, Dept.of Gastroenterology, University of Michigan and Elissa Ozanne, PhD, Dept of Population Health Sciences, University of Utah, will be seeking feedback on a survey assessing
Read more.